Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma

Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma

The human microbiome is a vast collection of microbial species that exist throughout the human body and regulate various bodily functions and phenomena. Of the microbial species that exist in the human microbiome, those within the archaea domain have not been characterized to the extent of those in...

Full description

Bibliographic Details
Main Authors:	Matthew Uzelac, Yuxiang Li, Jaideep Chakladar, Wei Tse Li, Weg M. Ongkeko
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	International Journal of Molecular Sciences
Subjects:	LUAD: lung adenocarcinoma LUSC lung squamous cell carcinoma ROS: reactive oxygen species TCGA: the Cancer Genome Atlas GSEA: Gene Set Enrichment Analysis NES: normalized enrichment score
Online Access:	https://www.mdpi.com/1422-0067/23/19/11566

Similar Items

Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
by: Talip Zengin, et al.
Published: (2021-02-01)

Characterization of tRNA-Derived Fragments in Lung Squamous Cell Carcinoma with Respect to Tobacco Smoke
by: Shruti Magesh, et al.
Published: (2023-03-01)

Editorial: Recent advances in the molecular genetics and precision medicine of lung carcinoma
by: Mehdi Pirooznia, et al.
Published: (2024-01-01)

Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development
by: Rong Wei, et al.
Published: (2020-08-01)

Differential Expression of AP-2 Transcription Factors Family in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma—A Bioinformatics Study
by: Dagmara Szmajda-Krygier, et al.
Published: (2023-02-01)

Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer
by: Yuan Zhuang, et al.
Published: (2021-03-01)

Comparative Analysis of Age- and Gender-Associated Microbiome in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
by: Lindsay M. Wong, et al.
Published: (2020-06-01)

Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods
by: Xia Li, et al.
Published: (2021-08-01)

Females and Males Show Differences in Early-Stage Transcriptomic Biomarkers of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
by: Quewang Liu, et al.
Published: (2021-02-01)

PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype
by: Stefano Lucà, et al.
Published: (2023-04-01)

Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas
by: Sheng Yang, et al.
Published: (2017-11-01)

TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
by: Donald Freudenstein, et al.
Published: (2020-06-01)

Screening the components of Saussurea involucrata for novel targets for the treatment of NSCLC using network pharmacology
by: Dongdong Zhang, et al.
Published: (2022-02-01)

Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma
by: Feiran Wei, et al.
Published: (2020-07-01)

Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes
by: Chong Zhang, et al.
Published: (2021-10-01)

Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma
by: Zhengtong Lv, et al.
Published: (2021-03-01)

Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma
by: Joseph C. Tsai, et al.
Published: (2021-08-01)

A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma
by: Yun-Qiang Zhang, et al.
Published: (2022-05-01)

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer
by: Zeguo Sun, et al.
Published: (2022-07-01)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
by: Chang S, et al.
Published: (2021-10-01)

Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma
by: Tianyu Fan, et al.
Published: (2022-11-01)

Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer
by: Jinyun Li, et al.
Published: (2020-03-01)

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data
by: Yishuang Cui, et al.
Published: (2023-10-01)

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
by: Liangliang Cai, et al.
Published: (2023-06-01)

Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
by: Alexander Chi, et al.
Published: (2021-06-01)

Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer
by: Jianglin Wang, et al.
Published: (2022-07-01)

An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
by: Jiali Liang, et al.
Published: (2022-11-01)

An introduction to effective use of enrichment analysis software
by: Tipney Hannah, et al.
Published: (2010-02-01)

Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis
by: Qiang Guo, et al.
Published: (2020-03-01)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
by: Longjun Yang, et al.
Published: (2022-03-01)

multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data
by: Sebastian Canzler, et al.
Published: (2020-12-01)

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors
by: Xiaozeng Lin, et al.
Published: (2023-09-01)

Identifying the tumor-associated macrophage of lung adenocarcinoma reveals immune landscape through omics data integration
by: Xu Zhang, et al.
Published: (2024-03-01)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
by: Duoduo Xu, et al.
Published: (2022-04-01)

The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B
by: Jaideep Chakladar, et al.
Published: (2020-06-01)

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers
by: Jaideep Chakladar, et al.
Published: (2020-09-01)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
by: Yejinpeng Wang, et al.
Published: (2019-10-01)

UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
by: Sitong Zhou, et al.
Published: (2021-02-01)

Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma
by: Jiacong Liu, et al.
Published: (2024-03-01)

Glioma Subtypes Based on the Activity Changes of Immunologic and Hallmark Gene Sets in Cancer
by: Sihan Chen
Published: (2022-06-01)